These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13867063)

  • 1. [The 2 types of lupus erythematosus plasma factors].
    BENCZE G; LAKATOS L
    Acta Rheumatol Scand; 1962; 8():52-6. PubMed ID: 13867063
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental studies on the role of the lupus erythematosus plasma factor.
    BENCZE G
    Acta Med Acad Sci Hung; 1961; 17():215-23. PubMed ID: 13867064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antinuclear factors and the protein spectrum in disseminated lupus erythematosus].
    MANDEMA E; POLLAK VE; KARK RM
    Ned Tijdschr Geneeskd; 1962 Jan; 106():143-5. PubMed ID: 14469209
    [No Abstract]   [Full Text] [Related]  

  • 4. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein.
    HOLMAN HR; KUNKEL HG
    Science; 1957 Jul; 126(3265):162-3. PubMed ID: 13442661
    [No Abstract]   [Full Text] [Related]  

  • 5. The association of lupus anticoagulant and anti-DNA binding in patients with systemic lupus erythematosus.
    Bennett RE; Calabrese LH; Lucas FV; Clough JD
    Cleve Clin Q; 1985; 52(2):115-8. PubMed ID: 3928199
    [No Abstract]   [Full Text] [Related]  

  • 6. Apheresis enhances the selective removal of antinuclear antibodies in systemic lupus erythematosus.
    Colburn KK; Gusewitch GA; Statian Pooprasert BS; Weisbart RH
    Clin Rheumatol; 1990 Dec; 9(4):475-82. PubMed ID: 2088644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of the correlation between the LE-phenomenon and antinuclear factor in systemic lupus erythematosus].
    Zhuravlev GI; Rodshteĭn OA; Shishkin VI
    Ter Arkh; 1971 Jul; 43(7):110-5. PubMed ID: 4113161
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluorescence demonstration of the antinuclear factor in the diagnosis of lupus erythematosus].
    Horácek J; Drazdáková M
    Arch Klin Exp Dermatol; 1970; 237(1):27-31. PubMed ID: 4906812
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].
    Boulila Elgaied A; Hintati B; Fakhfakh F; Karray H; Hachicha J; Jarraya A; Ayadi H
    Tunis Med; 1993 Feb; 71(2):91-5. PubMed ID: 8322428
    [No Abstract]   [Full Text] [Related]  

  • 10. An unusual case of systemic lupus erythematosus.
    Ramaiah RS; Biagi RW
    Br J Clin Pract; 1979 Jan; 33(1):34. PubMed ID: 86360
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hematologic forms of lupus erythematosus disseminatus with and without antinuclear factors. 25 case reports].
    Blétry O; Mathieu A; Piette JC; Meyer O; Conard J; Wechsler B; Godeau P
    Rev Med Interne; 1983 Mar; 4(1):41-6. PubMed ID: 6603004
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic lupus erythematosus initially presenting as idiopathic juvenile arthritis with positive antinuclear antibodies.
    Vuilleumier C; Sauvain MJ; Aebi C; Saurenmann T; Bianchetti MG
    Acta Paediatr; 2003 Apr; 92(4):512-3. PubMed ID: 12801125
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical and diagnostic value of detection of antinuclear factor, antibodies to double-helical DNA and cardiolipin in patients with systemic lupus erythematosus].
    Sozina AV; Ilivanova EP; Shul'man AM; Shul'man MA; Shemerovskaia TG; Lapin SV; Totolian AA
    Klin Lab Diagn; 2008 May; (5):44-7. PubMed ID: 18590168
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti RNP in systemic lupus erythematosus.
    Melek M; Erdmann MF; Negreiros PH; Skare TL
    Acta Reumatol Port; 2013; 38(2):136-7. PubMed ID: 24141353
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-DNA antibodies and circulating immune complexes in systemic lupus erythematosus.
    Phanichphant S; Petchclai B; Tanakitikul N
    J Med Assoc Thai; 1982 Jan; 65(1):18-22. PubMed ID: 6153036
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies.
    Fredi M; Cavazzana I; Zanola A; Carabellese N; Tincani A; Mahler M; Franceschini F
    Lupus; 2017 Sep; 26(10):1121-1122. PubMed ID: 28420064
    [No Abstract]   [Full Text] [Related]  

  • 17. [The new classification criteria for systemic lupus erythematosus (SLICC)].
    Costedoat-Chalumeau N; Francès C; Pouchot J; Piette JC
    Rev Med Interne; 2014 Aug; 35(8):487-90. PubMed ID: 24467799
    [No Abstract]   [Full Text] [Related]  

  • 18. New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.
    Pisetsky DS; Rovin BH; Lipsky PE
    Arthritis Rheumatol; 2017 Mar; 69(3):487-493. PubMed ID: 27899010
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradigm shift in antinuclear antibody negative lupus: Current evidence.
    Tiwary AK; Kumar P
    Indian J Dermatol Venereol Leprol; 2018; 84(4):384-387. PubMed ID: 29637910
    [No Abstract]   [Full Text] [Related]  

  • 20. Lupus erythematosus cell preparation-antinuclear factor incongruity. A review of diagnostic tests for systemic lupus erythematosus.
    Koller SR; Johnston CL; Moncure CW
    Am J Clin Pathol; 1976 Sep; 66(3):495-505. PubMed ID: 60880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.